ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 142 filers reported holding ARCUS BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,404,000 | -91.3% | 50,000 | -92.0% | 0.01% | -89.1% |
| Q4 2020 | $16,225,000 | +51.5% | 625,000 | 0.0% | 0.13% | +59.3% |
| Q3 2020 | $10,713,000 | -30.7% | 625,000 | 0.0% | 0.08% | -42.6% |
| Q2 2020 | $15,463,000 | +45.2% | 625,000 | -18.5% | 0.14% | -2.1% |
| Q1 2020 | $10,648,000 | +37.4% | 767,128 | 0.0% | 0.14% | +48.5% |
| Q4 2019 | $7,748,000 | +11.0% | 767,128 | 0.0% | 0.10% | +1.0% |
| Q3 2019 | $6,981,000 | +106.6% | 767,128 | +80.5% | 0.10% | +26.3% |
| Q2 2019 | $3,379,000 | -36.3% | 425,000 | 0.0% | 0.08% | -48.6% |
| Q1 2019 | $5,308,000 | +16.0% | 425,000 | 0.0% | 0.15% | -22.1% |
| Q4 2018 | $4,577,000 | – | 425,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |